Recent Quarter Total Invested
$1.18 B
Recent Quarter Institutional Ownership Percentage
102.44%
Total Invested of Last Quarter
$1.24 B
Ownership Percentage of Last Quarter
112.38%
Arcutis Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC | 08/05/2024 | 11.57 M | $107.62 M | -4.97% | 9.37% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 08/14/2024 | 10.00 M | $93.04 M | 27.00% | 8.10% |
| RUBRIC CAPITAL MANAGEMENT LP | 08/13/2024 | 9.82 M | $91.30 M | 30.71% | 7.95% |
| BLACKROCK INC. | 08/13/2024 | 8.62 M | $80.19 M | 29.49% | 7.76% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/15/2024 | 8.79 M | $81.70 M | 0.00% | 7.11% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2024 | 6.88 M | $63.98 M | -0.10% | 5.57% |
| VANGUARD GROUP INC | 08/13/2024 | 6.14 M | $57.14 M | 18.93% | 4.98% |
| STATE STREET CORP | 08/14/2024 | 5.13 M | $47.75 M | -41.54% | 4.16% |
| FRANKLIN RESOURCES INC | 08/14/2024 | 4.44 M | $41.28 M | -4.40% | 3.59% |
| MORGAN STANLEY | 10/17/2024 | 3.97 M | $36.95 M | -0.84% | 3.22% |
| GILDER GAGNON HOWE & CO LLC | 08/14/2024 | 3.62 M | $33.63 M | -14.60% | 2.93% |
| CITADEL ADVISORS LLC | 08/14/2024 | 2.93 M | $27.27 M | 53.20% | 2.38% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 2.53 M | $23.48 M | 18.82% | 2.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 2.42 M | $22.52 M | 22.82% | 1.96% |
| ENSIGN PEAK ADVISORS, INC | 08/13/2024 | 2.13 M | $19.84 M | -28.41% | 1.73% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2024 | 2.04 M | $18.98 M | 0.65% | 1.65% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 1.88 M | $17.50 M | 0.50% | 1.52% |
| GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2024 | 1.67 M | $15.51 M | -3.10% | 1.35% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 1.56 M | $14.49 M | 107.80% | 1.26% |
| TEJARA CAPITAL LTD | 08/14/2024 | 1.34 M | $12.50 M | 42.86% | 1.09% |
| J. GOLDMAN & CO LP | 08/14/2024 | 1.31 M | $12.20 M | -8.62% | 1.06% |
| CANDRIAM S.C.A. | 08/05/2024 | 1.31 M | $12.16 M | 100.00% | 1.06% |
| JPMORGAN CHASE & CO | 08/12/2024 | 1.29 M | $11.95 M | 28.48% | 1.04% |
| AMERICAN CENTURY COMPANIES INC | 08/07/2024 | 1.23 M | $11.45 M | 18.33% | 1.00% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2024 | 1.11 M | $10.36 M | 401.11% | 0.90% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 08/12/2024 | 1.03 M | $9.59 M | -48.76% | 0.83% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 1.01 M | $9.37 M | 364.52% | 0.82% |
| STEMPOINT CAPITAL LP | 08/13/2024 | 965,392 | $8.98 M | -56.24% | 0.78% |
| INVESCO LTD. | 08/13/2024 | 937,594 | $8.72 M | 7.48% | 0.76% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 851,324 | $7.92 M | 13.40% | 0.69% |
| EVERSEPT PARTNERS, LP | 08/14/2024 | 837,847 | $7.79 M | 100.00% | 0.68% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 807,334 | $7.51 M | 0.10% | 0.65% |
| TWO SEAS CAPITAL LP | 08/14/2024 | 762,190 | $7.09 M | -5.82% | 0.62% |
| NORTHERN TRUST CORP | 08/14/2024 | 751,850 | $6.99 M | 0.39% | 0.61% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 735,042 | $6.84 M | 196.17% | 0.60% |
| TREXQUANT INVESTMENT LP | 08/13/2024 | 667,259 | $6.21 M | 83.88% | 0.54% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 634,441 | $5.90 M | 31.06% | 0.51% |
| PRUDENTIAL FINANCIAL INC | 08/13/2024 | 572,615 | $5.33 M | -20.84% | 0.46% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 567,123 | $5.27 M | -33.32% | 0.46% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 563,171 | $5.24 M | -40.31% | 0.46% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 512,696 | $4.77 M | 35.26% | 0.42% |
| STEMPOINT CAPITAL LP | 08/13/2024 | 500,000 | $350,000 | 100.00% | 0.40% |
| IKARIAN CAPITAL, LLC | 08/14/2024 | 489,642 | $4.55 M | -16.96% | 0.40% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 488,600 | $4.54 M | 47.66% | 0.40% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 437,362 | $4.07 M | -43.98% | 0.35% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 390,202 | $3.63 M | 25.82% | 0.32% |
| LAZARD ASSET MANAGEMENT LLC | 08/14/2024 | 359,997 | $3.35 M | 100.00% | 0.29% |
| FEDERATED HERMES, INC. | 08/08/2024 | 350,114 | $3.26 M | 0.00% | 0.28% |
| FISHMAN JAY A LTD/MI | 08/05/2024 | 346,600 | $3.22 M | 54.53% | 0.28% |
| PDT PARTNERS, LLC | 08/15/2024 | 319,715 | $2.97 M | -0.16% | 0.26% |
Arcutis Biotherapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ARQT shares?
During the previous two years, 213 institutional investors and hedge funds held shares of Arcutis Biotherapeutics, Inc.. The most heavily invested institutionals were:
JENNISON ASSOCIATES LLC: 11.66 M
Rubric Capital Management LP: 10.97 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 10.72 M
BlackRock Funding, Inc. /DE: 9.03 M
Frazier Life Sciences Management, L.P.: 8.79 M
Polar Capital Holdings Plc: 6.88 M
-
What percentage of Arcutis Biotherapeutics, Inc. stock is owned by institutional investors?
102.44% of Arcutis Biotherapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ARQT ?
Institutional investors have bought a total of 128.76 M shares in the last 24 months. This purchase volume represents approximately $1.31 B in transactions.